Literature DB >> 28843813

Live baculovirus acts as a strong B and T cell adjuvant for monomeric and oligomeric protein antigens.

Suvi Heinimäki1, Kirsi Tamminen2, Maria Malm3, Timo Vesikari4, Vesna Blazevic5.   

Abstract

Recombinant proteins produced by baculovirus (BV) expression systems contain residual BV after crude purification. We studied adjuvant effect of BV on antibody and T cell responses against two model antigens, monomeric ovalbumin (OVA) protein and oligomeric norovirus (NoV) virus-like particles (VLPs). BALB/c mice were immunized intradermally with OVA alone or OVA formulated with live or inactivated BV, and VLP formulations comprised of chromatographically purified NoV GII.4 VLPs alone or mixed with BV, or of crude purified VLPs containing BV impurities from expression system. Live BV improved immunogenicity of NoV VLPs, sparing VLP dose up to 10-fold. Moreover, soluble OVA protein induced IgG2a antibodies and T cell response only when co-administered with live BV. BV adjuvant effect was completely abrogated by removal or inactivation of BV. These findings support the usage of crude purified proteins containing residual BV as vaccine antigens.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adjuvant; Baculovirus; Immunogenicity; Virus-like particle

Mesh:

Substances:

Year:  2017        PMID: 28843813     DOI: 10.1016/j.virol.2017.08.023

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone.

Authors:  Peter Pushko; Irina Tretyakova; Rachmat Hidajat; Xiangjie Sun; Jessica A Belser; Terrence M Tumpey
Journal:  Vaccine       Date:  2018-06-07       Impact factor: 3.641

2.  Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model.

Authors:  Zach Menne; Vasilis C Pliasas; Richard W Compans; Sheniqua Glover; Constantinos S Kyriakis; Ioanna Skountzou
Journal:  Virology       Date:  2021-08-05       Impact factor: 3.513

3.  BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.

Authors:  Aro Kim; Gyeongmin Lee; Ji-Hyeon Hwang; Jong-Hyeon Park; Min Ja Lee; Byounghan Kim; Su-Mi Kim
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

4.  Display of Porcine Epidemic Diarrhea Virus Spike Protein on Baculovirus to Improve Immunogenicity and Protective Efficacy.

Authors:  Chia-Yu Chang; Wei-Ting Hsu; Yu-Chan Chao; Hui-Wen Chang
Journal:  Viruses       Date:  2018-06-27       Impact factor: 5.048

5.  Recombinant neuraminidase pseudotyped baculovirus: a dual vector for delivery of Angiotensin II peptides and DNA vaccine.

Authors:  Irisa Trianti; Saengchai Akeprathumchai; Phenjun Mekvichitsaeng; Sansanalak Rachdawong; Kanokwan Poomputsa
Journal:  AMB Express       Date:  2018-10-16       Impact factor: 3.298

Review 6.  Baculovirus as a Tool for Gene Delivery and Gene Therapy.

Authors:  Chikako Ono; Toru Okamoto; Takayuki Abe; Yoshiharu Matsuura
Journal:  Viruses       Date:  2018-09-19       Impact factor: 5.048

7.  Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant.

Authors:  Kirsi Tamminen; Maria Malm; Timo Vesikari; Vesna Blazevic
Journal:  Viruses       Date:  2019-01-22       Impact factor: 5.048

8.  Vaccine containing G protein fragment and recombinant baculovirus expressing M2 protein induces protective immunity to respiratory syncytial virus.

Authors:  Yeong-Min Jo; Jungwoo Kim; Jun Chang
Journal:  Clin Exp Vaccine Res       Date:  2019-01-31

9.  The Potential of Influenza HA-Specific Immunity in Mitigating Lethality of Postinfluenza Pneumococcal Infections.

Authors:  Miriam Klausberger; Irina A Leneva; Irina N Falynskova; Kirill Vasiliev; Alexander V Poddubikov; Claudia Lindner; Nadezhda P Kartaschova; Oxana A Svitich; Marina Stukova; Reingard Grabherr; Andrej Egorov
Journal:  Vaccines (Basel)       Date:  2019-11-17

10.  Parenterally Administered Porcine Epidemic Diarrhea Virus-Like Particle-Based Vaccine Formulated with CCL25/28 Chemokines Induces Systemic and Mucosal Immune Protectivity in Pigs.

Authors:  Chin-Wei Hsu; Ming-Hao Chang; Hui-Wen Chang; Tzong-Yuan Wu; Yen-Chen Chang
Journal:  Viruses       Date:  2020-10-02       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.